BTK inhibitor Rilzabrutinib, Purity ≥98%

Synonym: 1575596-29-0; BTK inhibitor; PRN 1008; PRN-1008

CAS Number: 1575596-29-0
Compound CID: 73388818

Product Size

5 mg; 10 mg; 50 mg; 100 mg

Price

Datasheet

MSDS

Properties

Description

Rilzabrutinib is a compound designed to block Bruton’s tyrosine kinase (BTK), an enzyme essential for the proliferation and survival of certain cancerous B cells. It targets BLK, BMX, Btk, EGFR, BRBB2, BRBB4, ITK, RLK, and TEC.

Molecular Weight

665.76

Molecular Formula

C₃₆H₄₀FN₉O₃

Targets

BLK: 6.3 nM; BMX: 1 nM; Btk: 1.3 nM; EGFR: 520 nM; BRBB2: 3900 nM; BRBB4: 11.3 nM; ITK: 440 nM; RLK: 1.2 nM; TEC: 0.8 nM

Form

Lyophilized powder

Purity

Identity

Confirmed by NMR/HPLC/MS.

Applications

Rilzabrutinib is used in research focusing on managing autoimmune diseases by targeting BTK.